Drug Profile
Insulin - Diabecore Medical
Latest Information Update: 21 Jan 2022
Price :
$50
*
At a glance
- Originator Diabecore Medical
- Class Antihyperglycaemics; Hepatoprotectants; Insulins; Pancreatic hormones
- Mechanism of Action Ornithine decarboxylase stimulants; Phosphokinase stimulants; Protein tyrosine kinase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Diabetes mellitus
Most Recent Events
- 05 Apr 2000 Preclinical development for Diabetes mellitus in Canada (Unknown route)